The PINK1 Mitochondrial Signaling Pathway

PINK1 线粒体信号通路

基本信息

  • 批准号:
    7907111
  • 负责人:
  • 金额:
    $ 27.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mitochondria are ubiquitous and dynamic organelles of eukaryotic organisms critically involved in many cellular processes, including energy production, metabolism, redox control, and programmed cell death. The importance of properly functioning mitochondria to human health is underscored by the findings that mitochondrial dysfunction is responsible for more than 40 human diseases, including cancer, diabetes, obesity, ataxia, and neurodegenerative disorders such as Parkinson's, Alzheimer's, and Huntington's diseases. The long-term goal of this research is to understand, at the molecular level, how mitochondrial function is controlled in normal physiology, and how this process becomes dysregulated in disease states. Although reversible protein phosphorylation is a major mechanism for controlling numerous cellular processes, the role of phosphorylation in regulating mitochondrial function is poorly understood. Mitochondria has been increasingly recognized as centers for receiving, integrating, and transmitting cellular signals, however, very little is presently known about mitochondrial signaling pathways. PTEN- induced putative kinase 1 (PINK1) is a novel mitochondrial protein initially isolated in a screen for potential mediators of the tumor-suppressive activity of PTEN. A connection to cancer is also suggested by the finding that the expression of PINK1 is up-regulated in melanoma and colon carcinoma cells with high metastatic potential. Recently, mutations in the PINK1 gene were identified as a common cause for early- onset, autosomal recessive Parkinson's disease. In Drosophila, loss of PINK1 expression leads to mitochondrial defects and muscle and dopaminergic neuron degeneration. Despite the genetic evidence indicating an essential role of PINK1 in cell survival, how PINK1 regulates mitochondrial function is unknown and the substrates of PINK1 remain to be identified. In this project, the applicant's team will use a combination of biochemical, proteomic, molecular and cell biological approaches to investigate the signaling role of PINK1 in mitochondria, identify PINK1 downstream effectors, and elucidate the molecular mechanisms by which PINK1 protects cells against apoptosis. The results of the proposed studies should advance our knowledge of the fundamental mechanisms governing mitochondrial signaling in all eukaryotic cells, and facilitate the development of effective therapies for treating human mitochondrial diseases. PUBLIC HEALTH RELEVANCE: The importance of properly functioning mitochondria to human health is underscored by the findings that mitochondrial dysfunction is responsible for more than 40 human diseases, including Parkinson's disease, Alzheimer's disease, diabetes, and cancer. The goal of the proposed research is to understand, at the molecular level, how mitochondrial function is controlled in normal physiology and how this process becomes dysregulated in disease states. The results of the proposed studies will provide fundamental information needed for the development of effective therapeutics to treat numerous mitochondrial diseases in human.
描述(由申请人提供):线粒体是真核生物中普遍存在的动态细胞器,关键参与许多细胞过程,包括能量产生、代谢、氧化还原控制和程序性细胞死亡。研究结果强调了线粒体功能正常对人类健康的重要性:线粒体功能障碍导致 40 多种人类疾病,包括癌症、糖尿病、肥胖、共济失调以及帕金森病、阿尔茨海默病和亨廷顿病等神经退行性疾病。这项研究的长期目标是在分子水平上了解正常生理中线粒体功能如何受到控制,以及该过程在疾病状态下如何失调。尽管可逆的蛋白质磷酸化是控制许多细胞过程的主要机制,但人们对磷酸化在调节线粒体功能中的作用知之甚少。线粒体越来越被认为是接收、整合和传输细胞信号的中心,然而,目前人们对线粒体信号通路知之甚少。 PTEN 诱导的推定激酶 1 (PINK1) 是一种新型线粒体蛋白,最初是在筛选 PTEN 肿瘤抑制活性的潜在介质时分离出来的。 PINK1 的表达在具有高转移潜力的黑色素瘤和结肠癌细胞中上调的发现也表明与癌症有关。最近,PINK1 基因突变被确定为早发型常染色体隐性遗传帕金森病的常见原因。在果蝇中,PINK1 表达缺失会导致线粒体缺陷以及肌肉和多巴胺能神经元变性。尽管遗传证据表明 PINK1 在细胞存活中发挥重要作用,但 PINK1 如何调节线粒体功能尚不清楚,并且 PINK1 的底物仍有待确定。在该项目中,申请人团队将综合运用生化、蛋白质组学、分子和细胞生物学方法来研究PINK1在线粒体中的信号传导作用,鉴定PINK1下游效应子,并阐明PINK1保护细胞免于凋亡的分子机制。拟议研究的结果应增进我们对所有真核细胞线粒体信号传导基本机制的了解,并促进开发治疗人类线粒体疾病的有效疗法。 公共卫生相关性:线粒体功能障碍导致 40 多种人类疾病,包括帕金森病、阿尔茨海默病、糖尿病和癌症,这一发现强调了线粒体功能正常对人类健康的重要性。拟议研究的目标是在分子水平上了解线粒体功能在正常生理学中如何受到控制以及该过程在疾病状态下如何变得失调。拟议研究的结果将为开发治疗人类多种线粒体疾病的有效疗法提供所需的基本信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LIAN LI其他文献

LIAN LI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LIAN LI', 18)}}的其他基金

Molecular analysis of SORL1 function and dysfunction in Alzheimer's disease
阿尔茨海默病中 SORL1 功能和功能障碍的分子分析
  • 批准号:
    10661159
  • 财政年份:
    2023
  • 资助金额:
    $ 27.34万
  • 项目类别:
Sialoglycoproteomic network and target discovery for Alzheimer's disease
唾液酸糖蛋白质组网络和阿尔茨海默病的靶标发现
  • 批准号:
    10734612
  • 财政年份:
    2023
  • 资助金额:
    $ 27.34万
  • 项目类别:
SIMPLE-regulated trafficking and peripheral neuropathy
SIMPLE调节的运输和周围神经病变
  • 批准号:
    9321426
  • 财政年份:
    2015
  • 资助金额:
    $ 27.34万
  • 项目类别:
SIMPLE-regulated trafficking and peripheral neuropathy
SIMPLE调节的运输和周围神经病变
  • 批准号:
    9029639
  • 财政年份:
    2015
  • 资助金额:
    $ 27.34万
  • 项目类别:
Function and mechanism of a novel SUMO protease
新型SUMO蛋白酶的功能和机制
  • 批准号:
    8459248
  • 财政年份:
    2012
  • 资助金额:
    $ 27.34万
  • 项目类别:
Function and mechanism of a novel SUMO protease
新型SUMO蛋白酶的功能和机制
  • 批准号:
    8588945
  • 财政年份:
    2012
  • 资助金额:
    $ 27.34万
  • 项目类别:
Function and mechanism of a novel SUMO protease
新型SUMO蛋白酶的功能和机制
  • 批准号:
    8972020
  • 财政年份:
    2012
  • 资助金额:
    $ 27.34万
  • 项目类别:
Pathogenic Mechanisms of Environmental Toxicants in Parkinson's Disease
环境毒物对帕金森病的致病机制
  • 批准号:
    8250028
  • 财政年份:
    2008
  • 资助金额:
    $ 27.34万
  • 项目类别:
Pathogenic Mechanisms of Environmental Toxicants in Parkinson's Disease
环境毒物对帕金森病的致病机制
  • 批准号:
    7616565
  • 财政年份:
    2008
  • 资助金额:
    $ 27.34万
  • 项目类别:
The PINK1 Mitochondrial Signaling Pathway
PINK1 线粒体信号通路
  • 批准号:
    7810715
  • 财政年份:
    2008
  • 资助金额:
    $ 27.34万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 27.34万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 27.34万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 27.34万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 27.34万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 27.34万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 27.34万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 27.34万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 27.34万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 27.34万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 27.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了